Bridgefront Capital, LLC Sarepta Therapeutics, Inc. Transaction History
Bridgefront Capital, LLC
- $331 Million
- Q1 2025
A detailed history of Bridgefront Capital, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Bridgefront Capital, LLC holds 4,718 shares of SRPT stock, worth $86,197. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,718Holding current value
$86,197% of portfolio
0.09%Shares
5 transactions
Others Institutions Holding SRPT
# of Institutions
467Shares Held
82.5MCall Options Held
1.78MPut Options Held
1.39M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
State Street Corp Boston, MA4.07MShares$74.3 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X03.36MShares$61.5 Million0.12% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.67MShares$48.9 Million2.76% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...